Upstream Bio (UPB) EBT Margin (2023 - 2025)
Historic EBT Margin for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to 4938.36%.
- Upstream Bio's EBT Margin fell 23042600.0% to 4938.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 4364.31%, marking a year-over-year decrease of 17721000.0%. This contributed to the annual value of 2769.66% for FY2024, which is 12592000.0% down from last year.
- Latest data reveals that Upstream Bio reported EBT Margin of 4938.36% as of Q3 2025, which was down 23042600.0% from 4259.98% recorded in Q2 2025.
- Over the past 5 years, Upstream Bio's EBT Margin peaked at 1265.54% during Q3 2023, and registered a low of 4938.36% during Q3 2025.
- In the last 3 years, Upstream Bio's EBT Margin had a median value of 2875.1% in 2024 and averaged 3250.13%.
- As far as peak fluctuations go, Upstream Bio's EBT Margin tumbled by -6183600bps in 2024, and later tumbled by -26700500bps in 2025.
- Quarter analysis of 3 years shows Upstream Bio's EBT Margin stood at 2846.89% in 2023, then fell by -22bps to 3465.25% in 2024, then crashed by -43bps to 4938.36% in 2025.
- Its last three reported values are 4938.36% in Q3 2025, 4259.98% for Q2 2025, and 4818.02% during Q1 2025.